Caitong International Asset Management Co., LTD Uni Qure N.V. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Uni Qure N.V. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 475 shares of QURE stock, worth $6,735. This represents 0.01% of its overall portfolio holdings.
Number of Shares
475
Previous 475
-0.0%
Holding current value
$6,735
Previous $8.39 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding QURE
# of Institutions
170Shares Held
42.5MCall Options Held
2.61MPut Options Held
582K-
Eco R1 Capital, LLC San Francisco, CA3.4MShares$48.2 Million2.81% of portfolio
-
Vestal Point Capital, LP New York, NY3.03MShares$42.9 Million3.17% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$34.8 Million2.18% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.18MShares$30.8 Million0.56% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$28.2 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $663M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...